Michael Aldridge

Michael Aldridge

Chief Executive Officer bij Advanced Chemotherapy Technologies, Inc.

57 jaar
Health Technology
Finance
Consumer Services

Profiel

Michael Douglas Arthur Aldridge was the founder of Sirona Therapeutics Ltd.
founded in 2015, where he held the position of President, Chief Executive Officer & Director.
Currently, he is the Chief Executive Officer at Advanced Chemotherapy Technologies, Inc. since 2022 and a Director at University of Canterbury Foundation In America, Inc. since 2015.
He also served as a Director at Bear, Stearns & Co., Inc. in 2002, Pinnacle Investment Management Group Ltd.
from 2002 to 2003, and Codexis, Inc. from 2016 to 2018.
Additionally, he was an Independent Director at Allon Therapeutics, Inc. from 2012 to 2013.
Mr. Aldridge's education includes a graduate degree from Macquarie University and an undergraduate degree from the University of Canterbury.

Actieve functies van Michael Aldridge

BedrijvenFunctieBegin
University of Canterbury Foundation In America, Inc. Director/Board Member 01-01-2015
Chief Executive Officer 01-11-2022
Alle actieve functies van Michael Aldridge

Eerdere bekende functies van Michael Aldridge

BedrijvenFunctieEinde
HEXIMA LIMITED Chief Executive Officer 02-08-2022
CODEXIS, INC. Corporate Officer/Principal 17-08-2018
Founder 01-07-2017
QUESTCOR PHARMACEUTICALS INC Corporate Officer/Principal 01-09-2014
ALLON THERAPEUTICS INC. Director/Board Member 30-01-2013
Ervaring van Michael Aldridge in detail bekijken

Opleiding van Michael Aldridge

Macquarie University Graduate Degree
University of Canterbury Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Michael Aldridge in detail bekijken

Connecties

100 +

Eerstegraads connecties

15

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven4
CODEXIS, INC.

Process Industries

HEXIMA LIMITED

Health Technology

ALLON THERAPEUTICS INC.

Health Technology

PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED

Finance

Bedrijven in privébezit9

Finance

Health Technology

Health Technology

Volpe Brown Whelan & Co. LLC

Finance

Finance

Health Technology

Health Technology

Health Technology

University of Canterbury Foundation In America, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Michael Aldridge